CAPR logo

Capricor Therapeutics (CAPR)

Profile

Full Name

Capricor Therapeutics, Inc.

Ticker Symbol

CAPR

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 13, 2007

Indexes

Not included

Website

http://www.capricor.com

Employees

160

Key Details

Price

$13.03(-1.88%)

Market cap

$595.16M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$22.27M(-11.55% YoY)

Annual EPS

-$1.15(-38.55% YoY)

PE ratio

-

Next earnings date

May 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$13.03
CAPR price is $13.03

30-Day Relative Volume

0.61
CAPR 30-day relative volume is 0.61

Price Performance

Price Most recent change

-1.88%
CAPR price was down -1.88% on Apr 25, 2025

Price YTD change

-5.58%
CAPR price is down -5.58% since January 1st

Price 1-year change

+153.01%
CAPR price is up +153.01% year-on-year

Price 3-year change

+293.66%
CAPR price is up +293.66% over the past 3 years

Price Range

Price All-time high

$3500.00
CAPR price is currently -99.63% below its historical high of $3500.00

Price 3-year low

$2.68
CAPR price is currently +386.19% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$595.16M
CAPR market capitalization is $595.16 million

Market cap 3-year change

+639.21%
CAPR market capitalization is up +639.21% over the past 3 years

Market cap All-time high

$998.48M
CAPR market capitalization is currently -40.39% below its historical high of $998.48 million

Market cap sector rank

70.75%
CAPR market capitalization is higher than 70.75% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+44.54%
CAPR shares outstanding is up +44.54% year-on-year

Shares Outstanding 3-Year Change

+87.78%
CAPR shares outstanding is up +87.78% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.10
CAPR beta is 1.10

200-day SMA

$12.15
CAPR price is currently +7.21% above its 200-day simple moving average

50-day SMA

$12.43
CAPR price is currently +4.81% above its 50-day simple moving average

RSI

58.99
CAPR 14-day relative strength index is 58.99

Volume

0.61
CAPR 30-day relative volume is 0.61

ATR

$1.09
CAPR average true range is $1.09

10-day Historical Volatility

117.75%
CAPR 10-day historical volatility is 117.75%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$22.27M
CAPR annual revenue is $22.27 million

Revenue Analysts estimate

$63.26M
CAPR annual revenue is currently -64.79% lower than the consensus analysts' forecast

Revenue 1-year change

-11.55%
CAPR annual revenue is down -11.55% year-on-year

Revenue Sector rank

34.93%
CAPR annual revenue is higher than 34.93% of companies in Healthcare sector

EPS

EPS

-$1.15
CAPR annual earnings per share is -$1.15

EPS Analysts estimate

-$0.24
CAPR annual earnings per share is currently +371.31% higher than the consensus analysts' forecast

EPS 1-year change

-38.55%
CAPR annual earnings per share is down -38.55% year-on-year

EPS Sector rank

53.01%
CAPR annual earnings per share is higher than 53.01% of companies in Healthcare sector

Profit

Gross profit

-
CAPR annual gross profit value is unknown

Gross margin

-
CAPR annual gross profit margin value is unknown

Operating profit

-$42.56M
CAPR annual operating income is -$42.56 million

Operating margin

-191.13%
CAPR annual operating profit margin is -191.13%

Net income

-$40.47M
CAPR annual net profit is -$40.47 million

Net margin

-181.71%
CAPR annual net profit margin is -181.71%

Expenses

Total expenses

$64.84M
CAPR annual total expenses is $64.84 million

Operating expenses

$64.84M
CAPR annual total operating expenses is $64.84 million

Cost of goods sold

-
CAPR annual cost of goods sold value is unknown

Selling, general & administrative expenses

$14.87M
CAPR annual SGA is $14.87 million

Depreciation and amortization

$1.43M
CAPR annual depreciation & amortization is $1.43 million

Interest expense

-
CAPR annual interest expense value is unknown

Income tax

-
CAPR annual income tax value is unknown

EBIT & EBITDA

EBIT

-$42.56M
CAPR annual earnings before interest & taxes is -$42.56 million

EBITDA

-$42.56M
CAPR annual EBITDA is -$42.56 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$170.48M
CAPR annual total assets is $170.48 million

Non current assets

$7.10M
CAPR annual long term assets is $7.10 million

Current assets

$151.52M
CAPR annual total current assets is $151.52 million

Cash and cash equivalents

$11.29M
CAPR annual cash & cash equivalents is $11.29 million

Accounts receivable

$10.37M
CAPR annual accounts receivable is $10.37 million

Inventory

-
CAPR annual inventory value is unknown

Liabilities

Total liabilities

$25.02M
CAPR annual total liabilities is $25.02 million

Long term liabilities

$3.99M
CAPR annual total long term liabilities is $3.99 million

Current liabilities

$21.03M
CAPR annual total current liabilities is $21.03 million

Accounts payable

-
CAPR annual accounts payable value is unknown

Debt

Total debt

$1.45M
CAPR annual total debt is $1.45 million

Total debt 1-year change

-35.1%
CAPR annual total debt is down -35.1% year-on-year

Long term debt

$616.30K
CAPR annual long term debt is $616.30 thousand

Short term debt

$834.80K
CAPR annual short term debt is $834.80 thousand

Equity & Capital

Shareholders equity

$145.46M
CAPR annual stockholders equity is $145.46 million

Book value

$145.46M
CAPR annual book value is $145.46 million

Retained earnings

-$199.83M
CAPR annual retained earnings is -$199.83 million

Working capital

$142.36M
CAPR annual working capital is $142.36 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$40.00M
CAPR annual cash flow from operations is -$40.00 million

Cash from operations 1-year change

-56.25%
CAPR annual cash flow from operations is down -56.25% year-on-year

Cash from investing

-$116.18M
CAPR annual cash flow from investing activities is -$116.18 million

Cash from investing 1-year change

-2374.46%
CAPR annual cash flow from investing activities is down -2374.46% year-on-year

Cash from financing

$152.77M
CAPR annual cash flow from financing activities is $152.77 million

Cash from financing 1-year change

+497.23%
CAPR annual cash flow from financing activities is up +497.23% year-on-year

CAPEX

CAPEX

$1.54M
CAPR annual capital expenditures is $1.54 million

CAPEX 1-year change

-24.84%
CAPR annual capital expenditures is down -24.84% year-on-year

Free Cash Flow

Free cash flow

-$41.53M
CAPR annual free cash flow is -$41.53 million

Free cash flow 1-year change

-50.25%
CAPR annual free cash flow is down -50.25% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
CAPR annual gross profit margin value is unknown

Operating margin

-191.13%
CAPR annual operating profit margin is -191.13%

Net margin

-181.71%
CAPR annual net profit margin is -181.71%

ROA & ROE

ROA

-35.31%
CAPR annual return on assets is -35.31%

ROE

-48.16%
CAPR annual return on equity is -48.16%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CAPR price to earnings ratio value is unknown

PE ratio Sector rank

-
CAPR price to earnings ratio is unknown

PB Ratio

PB ratio

4.09
CAPR price to book ratio is 4.09

PB ratio Sector rank

78.65%
CAPR price to book ratio is higher than 78.65% of companies in Healthcare sector

PS Ratio

PS ratio

26.72
CAPR price to sales ratio is 26.72

PS ratio Sector rank

87.14%
CAPR price to sales ratio is higher than 87.14% of companies in Healthcare sector

Enterprise value

Enterprise value

$585.32M
CAPR enterprise value is $585.32 million

Enterprise value Sector rank

69.64%
CAPR enterprise value is higher than 69.64% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-14.10
CAPR EV/EBITDA is -14.10

EV/EBITDA Sector rank

8.71%
CAPR EV/EBITDA is higher than 8.71% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

7.77
CAPR annual current ratio is 7.77

Quick ratio

-
CAPR annual quick ratio value is unknown

Leverage

Debt to equity

0.00
CAPR annual debt to equity ratio is 0.00

Interest coverage ratio

-
CAPR annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
CAPR piotroski f-score value is unknown

Altman Z-Score

12.94
CAPR altman z-score is 12.94

Analyst ratings

Recent major analysts updates

Mar 20, 25 HC Wainwright & Co.
Buy
Mar 20, 25 Cantor Fitzgerald
Overweight
Mar 17, 25 HC Wainwright & Co.
Buy
Mar 4, 25 HC Wainwright & Co.
Buy
Jan 2, 25 HC Wainwright & Co.
Buy
Nov 18, 24 Jones Trading
Buy
Nov 14, 24 HC Wainwright & Co.
Buy
Nov 14, 24 Cantor Fitzgerald
Overweight
Jul 2, 24 HC Wainwright & Co.
Buy
May 17, 24 Oppenheimer
Outperform

Institutional Ownership

Similar stocks

CSTL logo
Castle Biosciences (CSTL)
CRMD logo
CorMedix (CRMD)
BFLY logo
Butterfly Network (BFLY)
GHRS logo
GH Research (GHRS)
RXST logo
RxSight (RXST)
BCYC logo
Bicycle Therapeutics (BCYC)
FLGT logo
Fulgent Genetics (FLGT)
PHAR logo
Pharming Group NV (PHAR)
SIBN logo
SI-BONE (SIBN)
  • What is the ticker symbol for Capricor Therapeutics?
  • Does Capricor Therapeutics pay dividends?
  • What sector is Capricor Therapeutics in?
  • What industry is Capricor Therapeutics in?
  • What country is Capricor Therapeutics based in?
  • When did Capricor Therapeutics go public?
  • Is Capricor Therapeutics in the S&P 500?
  • Is Capricor Therapeutics in the NASDAQ 100?
  • Is Capricor Therapeutics in the Dow Jones?
  • When was Capricor Therapeutics's last earnings report?
  • When does Capricor Therapeutics report earnings?
  • Should I buy Capricor Therapeutics stock now?

What is the ticker symbol for Capricor Therapeutics?

The ticker symbol for Capricor Therapeutics is NASDAQ:CAPR

Does Capricor Therapeutics pay dividends?

No, Capricor Therapeutics does not pay dividends

What sector is Capricor Therapeutics in?

Capricor Therapeutics is in the Healthcare sector

What industry is Capricor Therapeutics in?

Capricor Therapeutics is in the Biotechnology industry

What country is Capricor Therapeutics based in?

Capricor Therapeutics is headquartered in United States

When did Capricor Therapeutics go public?

Capricor Therapeutics's initial public offering (IPO) was on February 13, 2007

Is Capricor Therapeutics in the S&P 500?

No, Capricor Therapeutics is not included in the S&P 500 index

Is Capricor Therapeutics in the NASDAQ 100?

No, Capricor Therapeutics is not included in the NASDAQ 100 index

Is Capricor Therapeutics in the Dow Jones?

No, Capricor Therapeutics is not included in the Dow Jones index

When was Capricor Therapeutics's last earnings report?

Capricor Therapeutics's most recent earnings report was on Mar 19, 2025

When does Capricor Therapeutics report earnings?

The next expected earnings date for Capricor Therapeutics is May 13, 2025

Should I buy Capricor Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page